Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01653132
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:38.963868+00:00
Published At
2016-12-14T00:00:00+00:00
Record Updated At
2017-03-14
Results Posted At
2016-12-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Sialorrhea"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-03-14"
protocolSection.identificationModule.nctId
"NCT01653132"
protocolSection.identificationModule.officialTitle
"Randomized Double Blind Placebo Controlled Cross-Over Study of Incobotulinum Toxin A (Xeomin\u00ae) for Troublesome Sialorrhea in Parkinson\u0027s Disease (PD)/Parkinsonism"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-12-14"

Study condition terms

  • Sialorrhea (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.